Farringdon-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
327
Total Value
198269118
Accession Number
0001420506-25-001213
Form Type
13F-HR
Manager Name
Farringdon-Capital
Data Enrichment
95% identified
312 identified15 unidentified

Holdings

327 positions • $198.3M total value
Manager:
Search and click to pin securities to the top
Page 17 of 17
Esperion Therapeutics, Inc.
Shares:13.5K
Value:$19.5K
% of Portfolio:0.0% ($19.5K/$198.3M)
Editas Medicine, Inc.
Shares:16.3K
Value:$18.9K
% of Portfolio:0.0% ($18.9K/$198.3M)
Ventyx Biosciences, Inc.
Shares:16.5K
Value:$18.9K
% of Portfolio:0.0% ($18.9K/$198.3M)
CASSAVA SCIENCES INC
Shares:12.3K
Value:$18.5K
% of Portfolio:0.0% ($18.5K/$198.3M)
Leslie's, Inc.
Shares:23.3K
Value:$17.1K
% of Portfolio:0.0% ($17.1K/$198.3M)
NEKTAR THERAPEUTICS
Shares:21.3K
Value:$14.5K
% of Portfolio:0.0% ($14.5K/$198.3M)
ATOSSA THERAPEUTICS, INC.
Shares:13.3K
Value:$9.0K
% of Portfolio:0.0% ($9.0K/$198.3M)